Skip to content
GLP-1 Scorecard
Menu

Site position #44

Mint Med

By GLP-1 ScorecardUpdated
Offer review: November 2026. Factor scores were not reassessed in this update.

Prepaid cancellation can reprice the plan; processed prescriptions are final.

Our take

We would avoid a longer prepayment until you have a written exit calculation. Mint Med’s policy can reprice an early cancellation and makes processed prescriptions final.

Is it for you?Best fit and reasons to look elsewhere
Best for
Shoppers comfortable comparing a cash-pay telehealth purchase after clarifying the selected price and additional charges.
Look elsewhere if
Anyone who needs an uncomplicated refund on unused prepaid treatment or expects cancellation to reverse an already processed order.
Semaglutide
Product and catalog prices conflict; confirm selected plan charge and supply.
Tirzepatide
Catalog title and starting price differ; confirm selected charge and supply.
Coverage
Homepage says 35 states but lists 36; confirm treatment-specific eligibility.
Brand-name
Not confirmed
In this review
Visit Mint MedWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Line Mint Med up against its closest alternatives before comparing prices. The trial evidence behind the drugs themselves is in our research library, kept separate from these grades. Every listing is graded on the same six factors as this one. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe before you order. Compounded preparations are not FDA-approved, so the pharmacy and prescriber matter.

Semaglutide’s selector quotes $89 monthly, $255 billed every three months or $474 billed every six months; the longer options are labeled prepaid. These advertisements do not confirm your selected invoice or supplied quantity.

One month and a prepaid term buy different flexibility

The semaglutide page labels its longer options prepaid. That means the $85 or $79 monthly allocation belongs beside the actual $255 or $474 charge. We would use our six-month cost guide to compare cash leaving the account before deciding whether the longer term fits.

The Care Clinics comparison shows what to confirm when another provider’s package gives a different supply period.

A price lock still has purchase conditions

The semaglutide page promises a locked price and all doses included, but also says cancellation, refund, renewal, shipping and rate-lock terms apply. We would read those conditions alongside the selected prescription and full charge before relying on the headline.

If the price or terms here do not fit, our Lttl review and our WellMedr review set out the prices, renewal terms and what we could not verify for each. Both sellers pay us a commission when a reader signs up, which never changes a grade.

The catalog does not settle the price

The catalog lists semaglutide from $106 and tirzepatide from $179, although their linked titles advertise $89 and $119. It also advertises low-cost consultations without giving a complete treatment invoice. Tirzepatide’s selected billing terms and supplied quantity remain unconfirmed. We would resolve the displayed offer before paying.

Canceling is different from recovering a payment

The refund policy requires the official cancellation form at least 48 business hours before the next order-processing date. It says processed prescriptions cannot be canceled or refunded, even before shipment. Consultation fees become nonrefundable after the visit unless the provider finds medical ineligibility.

For prepaid terms, early cancellation can require paying the difference between promotional and full price. The policy does not give a worked calculation for unused treatment. Confirm that amount before committing; our cancellation guide separates stopping future orders from recovering money already paid.

State eligibility and support need a specific answer

The homepage says 35 states but lists 36 abbreviations. It describes payment before clinical review, an immediate refund after medical ineligibility, and portal access for ongoing questions. Live video or audio depends on state requirements. Confirm treatment eligibility at your address before purchase; the list alone does not verify an assigned clinician’s license.

Human support is advertised Monday–Friday, 9 a.m.–5 p.m. Eastern. That is a different expectation from a promise that a clinician will answer immediately. Ask how time-sensitive treatment questions reach the prescribing team and what happens outside those hours.

Identify the care and dispensing businesses

The terms name MINT MED, LLC as a platform connecting patients with independent providers, rather than the provider of medical services. They describe cash payment, possible third-party charges and automatic subscription renewal. The relationship between that entity and the business named in the FDA letter needs clarification.

The compliance page names Roderick Huff and describes use of 503A pharmacies and secure provider messaging. It also discusses prescriptions sent to an outside pharmacy. Those disclosures do not identify your assigned dispensing branch or independently establish credentials. Use our pharmacy verification guide after obtaining the dispenser’s exact identity.

Read the FDA record for what it actually says

FDA issued a June 8, 2026 warning letter to Glow Medispa, LLC dba Mint Med. It concerned website representations suggesting Mint Med compounded products when it did not. That is dated official evidence about labeling and promotion; it does not establish the quality of a particular prescription, a current enforcement action or the outcome of corrective work.

The historical letter does not settle present outcomes. We have not established whether FDA accepted corrective work or issued a closeout; neither outcome should be inferred from the dated letter.

Compare Mint Med

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value90/100
Dose & formulation80/100
Clinical oversight55/100
Labs & monitoring83/100
Fulfillment82/100
Contract terms86/100

Strengths

  • Published monthly and prepaid plan choices
  • Portal access for treatment questions

What to consider

  • Advertised prices conflict
  • Processed orders generally final
  • Prepaid cancellation can require repricing
  • Assigned pharmacy and clinician need confirmation

Bottom line — Grade C+

Factor scores not reassessed.

Site position #44 of 515. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Glow Medispa, LLC dba Mint Med in June 2026. See the FDA warning-letter database.

Closest here

The rankings grading nearest Mint Med — the realistic shortlist.

The 23 rankings nearest this one

View full scorecard rankings →

Prices and terms can change; confirm them with Mint Med. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard